The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report | Zendy

AI Assistant Blog Pricing

Open Access

The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report

Author(s) -

Manuela Stoicescu

Publication year - 2013

Publication title -

journal of developing drugs

Language(s) - English

Resource type - Journals

ISSN - 2329-6631

DOI - 10.4172/2329-6631.1000102

Subject(s) - medicine , interferon , hepatocellular carcinoma , breast carcinoma , chronic hepatitis , hepatitis c virus , virus , virology , oncology , immunology , breast cancer , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.